Lexicon Pharmaceuticals
LXRX
#6805
Rank
โ‚น74.64 B
Marketcap
โ‚น167.75
Share price
-4.40%
Change (1 day)
21.99%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น13.79

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น14.46. In 2025 the company made an earnings per share (EPS) of -โ‚น13.50 an increase over its 2024 EPS that were of -โ‚น61.70.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น13.792.16%
2025-โ‚น13.50-78.13%
2024-โ‚น61.70-20%
2023-โ‚น77.1331.15%
2022-โ‚น58.81-0%
2021-โ‚น58.8110.91%
2020-โ‚น53.03-145.08%
2019โ‚น117.62-206.09%
2018-โ‚น110.87-5.74%
2017-โ‚น117.62-10.95%
2016-โ‚น132.082640%
2015-โ‚น4.82-96.34%
2014-โ‚น131.56-2.53%
2013-โ‚น134.97-9.09%
2012-โ‚น148.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,795-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น521.58-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,041-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น563.03 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น965.06-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.93-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น72.31 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.64-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,824 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA